Since we have established that VEGFR2 expression is low in adult human liver22, 44, and that HCC can be treated in a mice model via the caudal vein, we believe 131I- FA8H1 has clinical translational potential in the targeted treatment of human HCC with high expression of VEGFR2. The gene discussed is KDR; the disease is hepatocellular carcinoma.